Status:
UNKNOWN
Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness
Lead Sponsor:
Miguel Ayala León
Conditions:
Echocardiography, Stress
COVID-19
Eligibility:
All Genders
18-45 years
Brief Summary
With the appearance of the new SARS-COV2 virus, additional challenges are being imposed on the medical community after the resolution of acute COVID-19 illness, resulting in specific pathophysiologic ...
Eligibility Criteria
Inclusion
- Having suffered mild COVID-19 illness
- PCR test negative after COVID-19 illness
- Men or women
- Age ≥18 years and \< 45.
- No history of other cardiovascular or lung disease.
- No cardiovascular risk factors, that is, arterial systemic hypertension, smoking, diabetes, dyslipidemia
- No ongoing or previous cardio or vasoactive treatment
- Able to use the semi-supine exercise bicycle
- Able to give informed consent
Exclusion
- Poor acoustic window.
- Tricuspid regurgitation more than mild
- Professional sports activity
- Pregnancy
- Obesity (body mass index \[BMI\], ≥30 kg/m2).
- Inability to provide consent
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04498299
Start Date
September 1 2020
End Date
November 30 2020
Last Update
August 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Beneficencia Española de Puebla
Puebla City, Mexico, 72090